簡要描述:Advanced Targeting Systems廣州鴻程代理廣州鴻程代理 始終致力于面向生命科學領(lǐng)域,從事科研機構(gòu)及生產(chǎn)企業(yè)所需的各類原料、試劑、耗材、儀器等的專業(yè)進出口公司。專門從事以抗*Beckman A63881的磁珠 現(xiàn)貨,moltox 11-101.5等現(xiàn)貨, 706020/706025現(xiàn)貨,Megazyme的大部分現(xiàn)貨
品牌 | 其他品牌 | 適用領(lǐng)域 | 科研 |
---|---|---|---|
產(chǎn)地 | 進口 | 加工定制 | 是 |
Advanced Targeting Systems 廣州鴻程代理
廣州鴻程生物有限公司一家專注于生命科學的科技企業(yè),由在國內(nèi)科研試劑領(lǐng)域有著豐富從業(yè)經(jīng)驗的技術(shù)團隊和管理團隊組建而成,專營進口生物試劑,科學儀器,實驗消耗品等。公司將不斷把上優(yōu)質(zhì)的產(chǎn)品引入國內(nèi)市場,滿足客戶的需求,公司也將緊跟生命科學的發(fā)展,為廣大科研工作者探索生命科學的奧秘奉獻綿薄之力.專門從事以抗cuxiao Beckman A63881的磁珠 現(xiàn)貨,moltox 11-101.5等現(xiàn)貨,transgenomic 706020/706025現(xiàn)貨,Megazyme的大部分現(xiàn)貨,LIST現(xiàn)貨,、ALZET大量現(xiàn)貨,Avanti 、tedpella 、BioLegend、Polyplus、jena bioscience、Mattek、MRC-Holland、polysciences、enzo、novus、TOCRIS、CAYMAN、Neuro Probe、cyguns、eylabs、NIBSC、chondrex、lc laboratories、BTI、etonbio
Advanced Targeting Systems(ATS)是位于加州圣地亞哥的一家生物技術(shù)公司,主要生產(chǎn)用于科研和藥物開發(fā)的靶試劑(targeting reagents)。ATS關(guān)于疼痛和藥物轉(zhuǎn)運的研究及臨床治療的兩個產(chǎn)品已獲保護。ATS公司主要進行神經(jīng)系統(tǒng)研究產(chǎn)品的開發(fā)和銷售。目前公司可提供用于神經(jīng)系統(tǒng)功能機制及相關(guān)疾病研究的靶毒素,抗體。
ATS公司產(chǎn)品的基礎(chǔ)技術(shù)并不局限于神經(jīng)領(lǐng)域,同樣可應用于當今的醫(yī)藥研究。ATS正在與*的科學家加強戰(zhàn)略合作,不斷開發(fā)和擴大產(chǎn)品線。
Catalog Number | 質(zhì)粒 | Catalog Number |
#0041 | Profect-P1-lipid based protein delivery reagent | 50 reactions |
#0042 | Profect-P2, a non-lipid based protein delivery reagent | 50 reactions |
#0042 | Profect-P2, a non-lipid based protein delivery reagent | 150 reactions |
#0043 | Profect-P1-lipid based protein delivery reagent | 150 reactions |
#0045 | Profect reporter kit: This kit consists of a positive control protein recombinant Beta galactosidase, 100 ug. Fluorescent Histone and fluorescent IgG) are provided free to assess easily the efficiency of protein delivery to the cytoplasm or nucleus | 100 ug Beta galactosidase |
#0060 | Targefect-siRNA kit | 100 reacns |
#0060 | Targefect-siRNA kit | 100 reacns |
#0061 | Targefect-F-2 plus Virofect enhancer | 100 reacns |
#0061 | Targefect-F-2 plus Virofect enhancer | 100 reacns |
#293/FS | Targefect-293FS | 1.2 ml (500 reacns) |
#C001 | pCMV-RedFluc plasmid vector- Control plasmid expressing red-emitting firefly luciferase (Luciola Italica) under control of the CMV promoter | 25 ug |
#S001 | psiScreen plasmid vector, a Gaussia luciferase –based vector to study miRNA expression in cells or gene silencing | 25 ug |
(#001) | Targefect F-1 | 0.6 ml / 100-500 |
(#002) | Targefect F-1 | 4 X 0.6 ml / 200-1000 |
(#003) | Targefect F-2 | 0.6 ml / 100-500 |
(#004) | Targefect F-2 | 4 X 0.6 ml / 200-1000 |
(#007) | Enhancer (Virofect)- Adenovirus derived formulation that dramatically enhances gene transfer when used with F-1 or F-2 | 600 µl |
(#008) | Peptide Enhancer | 600 ul |
(#293-01) | Targefect-293 (Targefect-F2) | 1.2 ml (400 reacns) |
(#293-01) | Targefect-293 (Targefect-F2) | 1.2 ml (400 reacns) |
(#BAC-01) | Targefect-BAC (Targefect F-2 & virofect) For transfection of Bacterial Artificial Chromosomes or large DNA fragments | 100 reacns |
(#COS-01) | Targefect-COS (Targefect F-2) | 1.2 ml (400 reacns) |
(#HEP-01) | Targefect-Hepatocyte (Targefect F-1 & virofect) For transfection of primary Human, rat, mouse and chimp hepatocytes | 200 reacns |
(#HUVEC-01) | Targefect-HUVEC (Targefect F-2 & virofect, peptide enhancer) | 100 reacns |
(#MEF-01) | Targefect-MEF (Targefect F-2 & virofect) Transfection of mouse embryo fibroblasts | 1.2ml (400 reacns) |
(#OST-01) | Targefect-Osteoblast (Targefect F-2 virofect) | 100 reacns |
(#RAW-01) | Targefect-RAW (Targefect F-2 & virofect) Transfection of Raw-264.7 cells and macrophages | 1.2ml (400 reacns) |
(#SMC-01) | Targefect-SMC (Targefect F-2 & virofect) | 1.2 ml (100 reacns) |
5X CLR-01 | 5X Cell Lysis reagent | 100 ml |